FDA authorizes Pfizer boosters for 12- to 15-year olds

January 3, 2022

JEFF KOWALSKY/AFP via Getty Images

(WASHINGTON) — The Food and Drug Administration on Monday approved Pfizer boosters for 12- to 15-year-olds.

The moves comes as schools reopen after the holiday break.

In a release, the FDA said it has amended the emergency use authorization for the Pfizer vaccine to also shorten the time between the completion of primary vaccination of the Pfizer vaccine and a booster dose to at least five months, instead of six, and to allow for a third primary series dose for certain immunocompromised children 5 through 11 years of age.

This is a developing story. Please check back for updates.

← Disabled community ‘left behind’ in vaccine rollout one year later
Five ways to deal with anxiety during the holidays amid the omicron surge →